FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015481718> ?p ?o ?g. }

• W3015481718 endingPage "251" @default.
• W3015481718 startingPage "244" @default.
• W3015481718 abstract "This study aimed to demonstrate the role of fractional concentration of exhaled nitric oxide (FeNO) in association with Global Initiative for Asthma (GINA) guidelines for treatment of adult patients with asthma. It was a prospective and randomized study. The symptomatic asthmatic patients were randomly divided into two groups: GINA group (followed GINA guidelines; N = 86) or GINA + FeNO group (followed GINA guidelines + FeNO for titration of inhaled corticosteroids - ICS; N = 90). They were followed-up for 9 months. In GINA group, 37.2% patients had no treatment and 62.8% patients discontinued treatment vs. 40.0% and 60.0% in GINA + FeNO, respectively. After 3, 6 and 9 months of treatment, the percentage of mild, moderate and severe asthma showed no significant difference between the two groups. At 9th month, Δ moderate asthma (reduction) in GINA + FeNO group was significantly higher than in the GINA group (−22.0% vs. −11.6%; P = 0.018). The improvement of asthma control test (ACT) score was not different between the groups at 9th month (12 ± 6 vs. 10 ± 5; P > 0.05); the level of FeNO reduction in GINA + FeNO group was significantly higher than that in GINA group (−42 ± 11 vs. −35 ± 9; P = 0.022). The daily dose of ICS in GINA + FeNO group was significantly lower than that in GINA group (397 ± 171 vs. 482 ± 240 mcg and 375 ± 203 vs. 424 ± 221 mcg; respectively) at the end of 6 and 9 months. The use of FeNO in association with GINA guidelines has a beneficial role for accurate daily dose of ICS in adult patients with asthma." @default.
• W3015481718 created "2020-04-17" @default.
• W3015481718 creator A5007232885 @default.
• W3015481718 creator A5008594937 @default.
• W3015481718 creator A5016266919 @default.
• W3015481718 creator A5027031429 @default.
• W3015481718 creator A5084477857 @default.
• W3015481718 creator A5091352445 @default.
• W3015481718 date "2020-09-01" @default.
• W3015481718 modified "2023-10-01" @default.
• W3015481718 title "The beneficial role of FeNO in association with GINA guidelines for titration of inhaled corticosteroids in adult asthma: A randomized study" @default.
• W3015481718 cites W1963731074 @default.
• W3015481718 cites W1974453301 @default.
• W3015481718 cites W1974698157 @default.
• W3015481718 cites W1992105306 @default.
• W3015481718 cites W1992864712 @default.
• W3015481718 cites W2017576187 @default.
• W3015481718 cites W2034391516 @default.
• W3015481718 cites W2067437401 @default.
• W3015481718 cites W2074582156 @default.
• W3015481718 cites W2086712302 @default.
• W3015481718 cites W2100578775 @default.
• W3015481718 cites W2101252196 @default.
• W3015481718 cites W2141343329 @default.
• W3015481718 cites W2145616458 @default.
• W3015481718 cites W2149411747 @default.
• W3015481718 cites W2151520766 @default.
• W3015481718 cites W2163414547 @default.
• W3015481718 cites W2166896195 @default.
• W3015481718 cites W2170413821 @default.
• W3015481718 cites W2600778706 @default.
• W3015481718 cites W4211006694 @default.
• W3015481718 cites W4211171942 @default.
• W3015481718 doi "https://doi.org/10.1016/j.advms.2020.03.001" @default.
• W3015481718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32276003" @default.
• W3015481718 hasPublicationYear "2020" @default.
• W3015481718 type Work @default.
• W3015481718 sameAs 3015481718 @default.
• W3015481718 citedByCount "8" @default.
• W3015481718 countsByYear W30154817182020 @default.
• W3015481718 countsByYear W30154817182021 @default.
• W3015481718 countsByYear W30154817182023 @default.
• W3015481718 crossrefType "journal-article" @default.
• W3015481718 hasAuthorship W3015481718A5007232885 @default.
• W3015481718 hasAuthorship W3015481718A5008594937 @default.
• W3015481718 hasAuthorship W3015481718A5016266919 @default.
• W3015481718 hasAuthorship W3015481718A5027031429 @default.
• W3015481718 hasAuthorship W3015481718A5084477857 @default.
• W3015481718 hasAuthorship W3015481718A5091352445 @default.
• W3015481718 hasBestOaLocation W30154817181 @default.
• W3015481718 hasConcept C126322002 @default.
• W3015481718 hasConcept C187212893 @default.
• W3015481718 hasConcept C2776042228 @default.
• W3015481718 hasConcept C2780333948 @default.
• W3015481718 hasConcept C2781142857 @default.
• W3015481718 hasConcept C2991922776 @default.
• W3015481718 hasConcept C71924100 @default.
• W3015481718 hasConceptScore W3015481718C126322002 @default.
• W3015481718 hasConceptScore W3015481718C187212893 @default.
• W3015481718 hasConceptScore W3015481718C2776042228 @default.
• W3015481718 hasConceptScore W3015481718C2780333948 @default.
• W3015481718 hasConceptScore W3015481718C2781142857 @default.
• W3015481718 hasConceptScore W3015481718C2991922776 @default.
• W3015481718 hasConceptScore W3015481718C71924100 @default.
• W3015481718 hasIssue "2" @default.
• W3015481718 hasLocation W30154817181 @default.
• W3015481718 hasOpenAccess W3015481718 @default.
• W3015481718 hasPrimaryLocation W30154817181 @default.
• W3015481718 hasRelatedWork W1908814627 @default.
• W3015481718 hasRelatedWork W1945679044 @default.
• W3015481718 hasRelatedWork W1988681733 @default.
• W3015481718 hasRelatedWork W2014029651 @default.
• W3015481718 hasRelatedWork W2021999298 @default.
• W3015481718 hasRelatedWork W2065474340 @default.
• W3015481718 hasRelatedWork W2164953438 @default.
• W3015481718 hasRelatedWork W2391351959 @default.
• W3015481718 hasRelatedWork W4252701617 @default.
• W3015481718 hasRelatedWork W65575745 @default.
• W3015481718 hasVolume "65" @default.
• W3015481718 isParatext "false" @default.
• W3015481718 isRetracted "false" @default.
• W3015481718 magId "3015481718" @default.
• W3015481718 workType "article" @default.